Elmiron is a drug that has been prescribed to millions of patients since 1996 for interstitial cystitis (IC), otherwise known as painful bladder syndrome. Starting in 2015, researchers began to discover a potential link between the drug and a serious eye disease called maculopathy. However, even as the evidence has piled up, Elmiron's manufacturer, Janssen Pharmaceutical, has failed to warn the public about these risks.
IC patients are typically prescribed 300 milligram daily doses of the drug. In more serious cases, doctors have been known to prescribe 800 or even 1500 milligrams. Millions of people are taking a drug that may one day rob them of their vision, and an untold number may have already suffered serious health consequences.
The potential risks associated with Elmiron were unknown until 2015, when doctors at Atlanta's Emory Eye Center encountered an eye condition they hadn't seen before in six women. This form of maculopathy didn't seem to have a cause. Further investigation revealed that all six women had been taking Elmiron for years.
Studies released in 2018 and 2019 further support the link between Elmiron and maculopathy. It is as yet unknown how Elmiron causes this condition.
Despite mounting evidence, eye disease is still not listed as a possible side effect by the manufacturer. There's no telling how many people have already suffered a serious eye injury due to their use of Elmiron, and hundreds of thousands of people are at risk.
If you or a loved one took Elmiron and were diagnosed with maculopathy, you could be owed compensation for medical costs, pain and suffering, lost wages, and other damages. We want to help you fight to get it.
Anyone taking this drug should talk to a healthcare professional about their options.
If you took Elmiron and were diagnosed with maculopathy, you should consider taking legal action against the drug's manufacturer. If you meet these criteria, you may have a case:
Every case is unique, but people who successfully file drug or medical device lawsuits can recover compensation for some or all of the following damages: